SURTAVI
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Public sites
- 56
- Start date
- Apr 1, 2012
The Queen’s Medical Center provides valve care through a multidisciplinary valve clinic and structural heart program, with cardiologists, cardiac surgeons, imaging specialists and advanced practice providers. Treatments include surgical and transcatheter aortic valve replacement, TAVR, MitraClip/mitral transcatheter edge-to-edge repair, balloon valvuloplasty, transcatheter mitral valve replacement, tricuspid interventions and paravalvular leak closure.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Honolulu, HI
Greenbrae, CA
San Francisco, CA